These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 5013819)
21. Inhibition of microsomal drug metabolism by anticholinesterase insecticides. Gundu Rao HR; Anders MW Bull Environ Contam Toxicol; 1973 Jan; 9(1):4-9. PubMed ID: 4205301 [No Abstract] [Full Text] [Related]
22. Partial purification and properties of cytochromes P-450 and P-448 from rat liver microsomes. Levin W; Lu AY; Ryan D; West S; Kuntzman R; Conney AH Arch Biochem Biophys; 1972 Dec; 153(2):543-53. PubMed ID: 4662099 [No Abstract] [Full Text] [Related]
23. A study of some possible mechanisms by which magnesium activates hepatic microsomal drug metabolism in vitro. Peters MA; Fouts JR J Pharmacol Exp Ther; 1970 Jun; 173(2):233-41. PubMed ID: 4393573 [No Abstract] [Full Text] [Related]
24. Effect of type I compounds on P-hydroxylation of aniline in vitro. Nakanishi S; Shioara E; Tsukada M; Kinoshita G Jpn J Pharmacol; 1972 Apr; 22(2):221-5. PubMed ID: 4538413 [No Abstract] [Full Text] [Related]
25. Interaction of parathion and malathion with hepatic cytochrome P-450 from rats treated with phenobarbital and carbon disulfide. Dalvi RR; Howell CD Drug Chem Toxicol; 1978; 1(2):191-202. PubMed ID: 755667 [TBL] [Abstract][Full Text] [Related]
26. [Effect of carbon tetrachloride on endoplasmic enzymes in rat liver]. Heni N; Remmer H Arch Toxikol; 1971; 28(1):1-11. PubMed ID: 4328041 [No Abstract] [Full Text] [Related]
27. Possible role of P-450 in the oxidation of drugs in liver microsomes. Kato R J Biochem; 1966 Jun; 59(6):574-83. PubMed ID: 4381416 [No Abstract] [Full Text] [Related]
28. Effect of adrenalectomy or alloxan diabetes on the substrate interaction with cytochrome P-450 in the oxidation of drugs by liver microsomes. Kato R; Takanaka A; Onoda K Biochem Pharmacol; 1971 Feb; 20(2):447-58. PubMed ID: 5150143 [No Abstract] [Full Text] [Related]
29. The effect of hemorrhage on the rate of hexobarbital biotransformation in the dog. Cumming JF; McClung HW; Mannering GJ J Pharmacol Exp Ther; 1971 Sep; 178(3):595-601. PubMed ID: 5571907 [No Abstract] [Full Text] [Related]
31. Aryl 4-hydroxylase, cytochrome P-450 and microsomal lipids in essential fatty acid deficiency. Kaschnitz R Hoppe Seylers Z Physiol Chem; 1970 Jun; 351(6):771-4. PubMed ID: 5425949 [No Abstract] [Full Text] [Related]
32. Oxidative drug metabolism in human liver microsomes. Nelson EB; Raj PP; Belfi KJ; Masters BS J Pharmacol Exp Ther; 1971 Sep; 178(3):580-8. PubMed ID: 4398379 [No Abstract] [Full Text] [Related]
33. [Spectral properties of cytochrome P450 following induction with phenobarbital, benzopyrene and methylcholanthrene]. Remmer H; Greim G; Hildebrandt A Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 260(2):189-90. PubMed ID: 4239220 [No Abstract] [Full Text] [Related]
34. Effects of extraction with isooctane upon the properties of liver microsomes. Leibman KC; Estalbrook RW Mol Pharmacol; 1971 Jan; 7(1):26-32. PubMed ID: 5552249 [No Abstract] [Full Text] [Related]
35. Properties of a solubilized form of the cytochrome P-450-containing mixed-function oxidase of liver microsomes. Lu AY; Strobel HW; Coon MJ Mol Pharmacol; 1970 May; 6(3):213-20. PubMed ID: 4315336 [No Abstract] [Full Text] [Related]
36. Evidence for an inhibitory product-cytochrome P-450 complex generated during benzphetamine metabolism by liver microsomes. Werringloer J; Estabrook RW Life Sci; 1973 Nov; 13(10):1319-30. PubMed ID: 4148650 [No Abstract] [Full Text] [Related]
37. [Stimulation of drug oxidation in kidney microsomes by phenobarbital]. Uehleke H; Greim H Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 261(2):152-61. PubMed ID: 4235047 [No Abstract] [Full Text] [Related]
38. A study of the modified type II spectral change produced by the interaction of agroclavine with cytochrome P-450. Wilson BJ; Orrenius S Biochim Biophys Acta; 1972 Jan; 261(1):94-101. PubMed ID: 5012477 [No Abstract] [Full Text] [Related]
39. Species difference in drug metabolism by liver microsomes in alloxan diabetic or fasted animals. II. The substrate interaction with cytochrome P-450 in drug oxidation. Kato R; Onoda K; Takanaka A Jpn J Pharmacol; 1970 Dec; 20(4):554-61. PubMed ID: 5312937 [No Abstract] [Full Text] [Related]
40. Studies of the mechanisms of metabolism of diethyl p-nitrophenyl phosphorothionate (parathion) by rabbit liver microsomes. Norman BJ; Vaughn WK; Neal RA Biochem Pharmacol; 1973 May; 22(9):1091-101. PubMed ID: 4695668 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]